Morgan Stanley Seer, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Seer, Inc. stock. As of the latest transaction made, Morgan Stanley holds 330,717 shares of SEER stock, worth $687,891. This represents 0.0% of its overall portfolio holdings.

Number of Shares

330,717

Previous 583,603 43.33%

Holding current value

$687,891

Previous $1.35 Million 58.61%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.69 - $2.47 $427,377 - $624,628	-252,886 Reduced 43.33%	330,717 $558,000
Q4 2024 Feb 14, 2025	BUY	$1.85 - $2.55 $688,568 - $949,107	372,199 Added 176.06%	583,603 $1.35 Million
Q3 2024 May 14, 2025	SELL	$1.59 - $2.07 $168,772 - $219,722	-106,146 Reduced 33.43%	211,404 $414,000
Q3 2024 Nov 14, 2024	SELL	$1.59 - $2.07 $168,772 - $219,722	-106,146 Reduced 33.43%	211,404 $414,000
Q2 2024 May 14, 2025	SELL	$1.65 - $2.24 $438,987 - $595,958	-266,053 Reduced 45.59%	317,550 $533,000
Q2 2024 Oct 17, 2024	SELL	$1.65 - $2.24 $162,543 - $220,664	-98,511 Reduced 23.68%	317,550 $533,000
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.24 $162,543 - $220,664	-98,511 Reduced 23.68%	317,550 $533,000
Q1 2024 Oct 17, 2024	BUY	$1.54 - $2.09 $151,706 - $205,887	98,511 Added 31.02%	416,061 $790,000
Q1 2024 Aug 16, 2024	SELL	$1.54 - $2.09 $58,586 - $79,509	-38,043 Reduced 8.38%	416,061 $790,000
Q1 2024 May 15, 2024	SELL	$1.54 - $2.09 $58,586 - $79,509	-38,043 Reduced 8.38%	416,061 $790,000
Q4 2023 Aug 16, 2024	BUY	$1.47 - $2.22 $200,734 - $303,149	136,554 Added 43.0%	454,104 $880,000
Q4 2023 Feb 13, 2024	BUY	$1.47 - $2.22 $361,821 - $546,424	246,137 Added 118.35%	454,104 $880,000
Q3 2023 Nov 15, 2023	SELL	$2.18 - $5.52 $254,844 - $645,293	-116,901 Reduced 35.98%	207,967 $459,000
Q2 2023 Aug 14, 2023	BUY	$3.16 - $4.96 $272,970 - $428,459	86,383 Added 36.22%	324,868 $1.39 Million
Q1 2023 May 15, 2023	BUY	$3.6 - $5.88 $194,749 - $318,090	54,097 Added 29.34%	238,485 $920,000
Q4 2022 Feb 14, 2023	SELL	$5.03 - $8.58 $3.25 Million - $5.54 Million	-645,954 Reduced 77.79%	184,388 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$7.7 - $13.31 $736,312 - $1.27 Million	95,625 Added 13.02%	830,342 $6.43 Million
Q2 2022 Oct 27, 2022	SELL	$6.72 - $16.07 $548,607 - $1.31 Million	-81,638 Reduced 10.0%	734,717 $6.58 Million
Q2 2022 Aug 15, 2022	SELL	$6.72 - $16.07 $548,607 - $1.31 Million	-81,638 Reduced 10.0%	734,717 $6.58 Million
Q1 2022 Oct 27, 2022	BUY	$11.88 - $23.4 $969,859 - $1.91 Million	81,638 Added 11.11%	816,355 $12.4 Million
Q1 2022 May 13, 2022	SELL	$11.88 - $23.4 $6.25 Million - $12.3 Million	-526,211 Reduced 39.19%	816,355 $12.4 Million
Q4 2021 Feb 14, 2022	BUY	$21.08 - $38.51 $7.16 Million - $13.1 Million	339,581 Added 33.86%	1,342,566 $30.6 Million
Q3 2021 Nov 15, 2021	BUY	$27.67 - $45.04 $27.8 Million - $45.2 Million	1,002,985 New	1,002,985 $34.6 Million

Others Institutions Holding SEER

# of Institutions

Shares Held

32.6M

Call Options Held

200

Put Options Held

1.4K

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $122M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account